8-K Announcements
6May 4, 2026·SEC
Feb 19, 2026·SEC
Feb 5, 2026·SEC
AMN Healthcare Services, Inc. (AMN) fundamental analysis — strengths, weaknesses & financial health based on data analysis
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
AMN Healthcare Services, Inc. (AMN) stock price & volume — 10-year historical chart
AMN Healthcare Services, Inc. (AMN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
AMN Healthcare Services, Inc. (AMN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 19, 2026 | $0.22vs $0.22+0.0% | $748Mvs $724M+3.4% |
| Q4 2025 | Nov 6, 2025 | $0.39vs $0.19+105.3% | $634Mvs $723M-12.3% |
| Q3 2025 | Aug 7, 2025 | $0.30vs $0.17+76.5% | $658Mvs $640M+2.9% |
| Q2 2025 | May 8, 2025 | $0.45vs $0.19+136.8% | $690Mvs $670M+2.9% |
AMN Healthcare Services, Inc. (AMN) competitors in Healthcare staffing and facility services — business model, growth, and fundamentals comparison
AMN Healthcare Services, Inc. (AMN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
AMN Healthcare Services, Inc. (AMN) annual income statement — 10-year revenue, gross profit & net income history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 1.99B | 2.14B | 2.22B | 2.39B | 3.98B | 5.24B | 3.79B | 2.98B | 2.73B |
| Revenue Growth % | 4.53% | 7.42% | 4.03% | 7.72% | 66.45% | 31.6% | -27.73% | -21.26% | -8.49% |
| Cost of Goods Sold | 1.34B | 1.44B | 1.48B | 1.6B | 2.67B | 3.53B | 2.54B | 2.06B | 2.1B |
| COGS % of Revenue | 67.59% | 67.4% | 66.54% | 66.92% | 67.13% | 67.26% | 67.02% | 69.19% | 77.07% |
| Gross Profit | 644.42M▲ 0% | 696.38M▲ 8.1% | 743.47M▲ 6.8% | 791.78M▲ 6.5% | 1.31B▲ 65.4% | 1.72B▲ 31.1% | 1.25B▼ 27.2% | 919.38M▼ 26.4% | 626.19M▼ 31.9% |
| Gross Margin % | 32.41% | 32.6% | 33.46% | 33.08% | 32.87% | 32.74% | 32.98% | 30.81% | 22.93% |
| Gross Profit Growth % | 3.98% | 8.06% | 6.76% | 6.5% | 65.4% | 31.08% | -27.21% | -26.43% | -31.89% |
| Operating Expenses | 431.98M | 493.56M | 566.55M | 642.51M | 831.6M | 1.07B | 911.15M | 1.02B | 593.02M |
| OpEx % of Revenue | 21.72% | 23.11% | 25.5% | 26.84% | 20.87% | 20.4% | 24.05% | 34.25% | 21.72% |
| Selling, General & Admin | 399.7M | 452.32M | 508.03M | 549.75M | 730.45M | 936.58M | 756.24M | 632.49M | 593.02M |
| SG&A % of Revenue | 20.1% | 21.18% | 22.86% | 22.97% | 18.33% | 17.86% | 19.96% | 21.2% | 21.72% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 32.28M | 41.24M | 58.52M | 92.77M | 101.15M | 133.01M | 154.91M | 389.56M | 0 |
| Operating Income | 212.44M▲ 0% | 202.83M▼ 4.5% | 176.91M▼ 12.8% | 149.26M▼ 15.6% | 478M▲ 220.2% | 647.1M▲ 35.4% | 338.43M▼ 47.7% | -102.67M▼ 130.3% | 33.17M▲ 132.3% |
| Operating Margin % | 10.68% | 9.5% | 7.96% | 6.24% | 12% | 12.34% | 8.93% | -3.44% | 1.21% |
| Operating Income Growth % | 10.86% | -4.52% | -12.78% | -15.63% | 220.23% | 35.38% | -47.7% | -130.34% | 132.3% |
| EBITDA | 244.72M | 244.06M | 235.44M | 243.45M | 581.7M | 784.21M | 499.36M | 71.11M | 189.77M |
| EBITDA Margin % | 12.31% | 11.43% | 10.6% | 10.17% | 14.6% | 14.96% | 13.18% | 2.38% | 6.95% |
| EBITDA Growth % | 10.61% | -0.27% | -3.54% | 3.41% | 138.94% | 34.82% | -36.32% | -85.76% | 166.88% |
| D&A (Non-Cash Add-back) | 32.28M | 41.24M | 58.52M | 94.19M | 103.7M | 137.11M | 160.93M | 173.78M | 156.6M |
| EBIT | 212.44M | 202.83M | 176.91M | 149.26M | 478M | 647.1M | 338.43M | -102.67M | -55.47M |
| Net Interest Income | -19.68M | -16.14M | -28.43M | -57.74M | -34.08M | -40.4M | -54.14M | -69.9M | -45.59M |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 19.68M | 16.14M | 28.43M | 57.74M | 34.08M | 40.4M | 54.14M | 69.9M | 45.59M |
| Other Income/Expense | -19.68M | -16.14M | -28.43M | -57.74M | -34.08M | -40.4M | -54.14M | -69.9M | -134.23M |
| Pretax Income | 192.76M▲ 0% | 186.69M▼ 3.2% | 148.49M▼ 20.5% | 91.52M▼ 38.4% | 443.92M▲ 385.0% | 606.7M▲ 36.7% | 284.29M▼ 53.1% | -172.57M▼ 160.7% | -101.06M▲ 41.4% |
| Pretax Margin % | 9.69% | 8.74% | 6.68% | 3.82% | 11.14% | 11.57% | 7.5% | -5.78% | -3.7% |
| Income Tax | 60.2M | 44.94M | 34.5M | 20.86M | 116.53M | 162.65M | 73.61M | -25.59M | -5.36M |
| Effective Tax Rate % | 31.23% | 24.07% | 23.23% | 22.79% | 26.25% | 26.81% | 25.89% | 14.83% | 5.3% |
| Net Income | 132.56M▲ 0% | 141.74M▲ 6.9% | 113.99M▼ 19.6% | 70.67M▼ 38.0% | 327.39M▲ 363.3% | 444.05M▲ 35.6% | 210.68M▼ 52.6% | -146.98M▼ 169.8% | -95.7M▲ 34.9% |
| Net Margin % | 6.67% | 6.64% | 5.13% | 2.95% | 8.22% | 8.47% | 5.56% | -4.93% | -3.5% |
| Net Income Growth % | 25.25% | 6.93% | -19.58% | -38.01% | 363.3% | 35.63% | -52.56% | -169.76% | 34.89% |
| Net Income (Continuing) | 132.56M | 141.74M | 113.99M | 70.67M | 327.39M | 444.05M | 210.68M | -146.98M | -95.7M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 2.68▲ 0% | 2.91▲ 8.6% | 2.40▼ 17.5% | 1.48▼ 38.3% | 6.81▲ 360.1% | 9.90▲ 45.4% | 5.36▼ 45.9% | -3.85▼ 171.8% | -2.48▲ 35.6% |
| EPS Growth % | 24.65% | 8.58% | -17.53% | -38.33% | 360.14% | 45.37% | -45.86% | -171.83% | 35.58% |
| EPS (Basic) | 2.77 | 2.99 | 2.44 | 1.49 | 6.87 | 9.96 | 5.38 | -3.85 | -2.48 |
| Diluted Shares Outstanding | 49.43M | 48.67M | 47.59M | 47.69M | 48.05M | 44.87M | 39.34M | 38.19M | 38.52M |
| Basic Shares Outstanding | 47.81M | 47.37M | 46.7M | 47.42M | 47.69M | 44.59M | 39.17M | 38.19M | 38.52M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
AMN Healthcare Services, Inc. (AMN) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 474.15M | 482.17M | 560.5M | 533.74M | 1.35B | 1.09B | 841.68M | 594.91M | 545.38M |
| Cash & Short-Term Investments | 15.15M | 13.86M | 82.98M | 29.21M | 180.93M | 64.52M | 32.94M | 10.65M | 33.97M |
| Cash Only | 15.15M | 13.86M | 82.98M | 29.21M | 180.93M | 64.52M | 32.94M | 10.65M | 33.97M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 407.41M | 416.81M | 431.38M | 450.08M | 1.03B | 953.25M | 746.54M | 519.98M | 439.11M |
| Days Sales Outstanding | 74.78 | 71.22 | 70.86 | 68.63 | 94.25 | 66.36 | 71.91 | 63.61 | 58.7 |
| Inventory | 57.91M | 39.54M | 0 | 38.85M | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 15.73 | 10.02 | - | 8.85 | - | - | - | - | - |
| Other Current Assets | 35.09M | 39.09M | 34.46M | 1.96M | 66.83M | 57.16M | 40.32M | 41.77M | 72.3M |
| Total Non-Current Assets | 779.8M | 1.01B | 1.37B | 1.82B | 1.78B | 1.79B | 2.08B | 1.82B | 1.55B |
| Property, Plant & Equipment | 73.43M | 90.42M | 194.7M | 193.91M | 154.88M | 165.54M | 225.93M | 218.38M | 136.36M |
| Fixed Asset Turnover | 27.08x | 23.62x | 11.41x | 12.34x | 25.72x | 31.67x | 16.77x | 13.66x | 20.02x |
| Goodwill | 340.6M | 438.51M | 595.55M | 864.49M | 892.34M | 935.36M | 1.11B | 897.46M | 755.81M |
| Intangible Assets | 227.1M | 326.15M | 398.47M | 564.91M | 514.46M | 476.83M | 474.13M | 381.36M | 283.53M |
| Long-Term Investments | -27.04M | -27.33M | 0 | 0 | 0 | 0 | 0 | 0 | 45.61M |
| Other Non-Current Assets | 138.68M | 155.48M | 182.42M | 129.26M | 221.15M | 216.97M | 271.1M | 297.78M | 282.55M |
| Total Assets | 1.25B▲ 0% | 1.49B▲ 19.0% | 1.93B▲ 29.4% | 2.35B▲ 21.8% | 3.13B▲ 33.1% | 2.89B▼ 7.8% | 2.92B▲ 1.2% | 2.42B▼ 17.4% | 2.09B▼ 13.3% |
| Asset Turnover | 1.59x | 1.43x | 1.15x | 1.02x | 1.27x | 1.82x | 1.30x | 1.24x | 1.30x |
| Asset Growth % | 5.65% | 19.04% | 29.4% | 21.84% | 33.07% | -7.78% | 1.25% | -17.39% | -13.31% |
| Total Current Liabilities | 265.27M | 307.27M | 378.11M | 422.96M | 969.39M | 857.93M | 656.12M | 545.78M | 577.61M |
| Accounts Payable | 73.21M | 82.43M | 102.55M | 107.45M | 339.01M | 373.32M | 177.11M | 100.92M | 84.94M |
| Days Payables Outstanding | 19.88 | 20.9 | 25.31 | 24.48 | 46.26 | 38.64 | 25.45 | 17.84 | 14.73 |
| Short-Term Debt | 0 | 0 | 0 | 4.69M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 8.38M | 12.37M | 11.79M | 11M | 157.05M | 33.29M | 20.01M | 66.36M | 0 |
| Other Current Liabilities | 62.26M | 88.79M | 149.71M | 167.37M | 250.48M | 251.95M | 223.39M | 237.53M | 486.66M |
| Current Ratio | 1.79x | 1.57x | 1.48x | 1.26x | 1.39x | 1.27x | 1.28x | 1.09x | 0.94x |
| Quick Ratio | 1.57x | 1.44x | 1.48x | 1.17x | 1.39x | 1.27x | 1.28x | 1.09x | 0.94x |
| Cash Conversion Cycle | 70.63 | 60.35 | - | 53 | - | - | - | - | - |
| Total Non-Current Liabilities | 426.16M | 546.46M | 816.8M | 1.11B | 1B | 986.78M | 1.44B | 1.16B | 874.39M |
| Long-Term Debt | 319.84M | 440.61M | 617.16M | 857.96M | 842.32M | 843.5M | 1.3B | 1.06B | 767.05M |
| Capital Lease Obligations | 0 | 0 | 91.21M | 77.8M | 13.36M | 9.36M | 37.6M | 35.73M | 30.14M |
| Deferred Tax Liabilities | 27.04M | 27.33M | 46.62M | 0 | 47.81M | 22.71M | 23.35M | 0 | 0 |
| Other Non-Current Liabilities | 106.31M | 77.66M | 61.81M | 107.91M | 96.99M | 111.21M | 71.38M | 71.72M | 77.19M |
| Total Liabilities | 691.43M | 853.73M | 1.19B | 1.53B | 1.97B | 1.84B | 2.09B | 1.71B | 1.45B |
| Total Debt | 319.84M | 440.61M | 722.31M | 955.48M | 867.07M | 860.96M | 1.35B | 1.1B | 803.2M |
| Net Debt | 304.7M | 426.75M | 639.33M | 926.27M | 686.14M | 796.43M | 1.32B | 1.09B | 769.23M |
| Debt / Equity | 0.57x | 0.69x | 0.98x | 1.17x | 0.75x | 0.82x | 1.62x | 1.55x | 1.25x |
| Debt / EBITDA | 1.31x | 1.81x | 3.07x | 3.92x | 1.49x | 1.10x | 2.70x | 15.44x | 4.23x |
| Net Debt / EBITDA | 1.25x | 1.75x | 2.72x | 3.80x | 1.18x | 1.02x | 2.64x | 15.29x | 4.05x |
| Interest Coverage | 10.80x | 12.56x | 6.22x | 2.59x | 14.03x | 16.02x | 6.25x | -1.47x | -1.22x |
| Total Equity | 562.53M▲ 0% | 638.99M▲ 13.6% | 736.74M▲ 15.3% | 819.68M▲ 11.3% | 1.16B▲ 41.8% | 1.04B▼ 10.2% | 831.26M▼ 20.3% | 706.62M▼ 15.0% | 642.11M▼ 9.1% |
| Equity Growth % | 25.18% | 13.59% | 15.3% | 11.26% | 41.77% | -10.19% | -20.35% | -14.99% | -9.13% |
| Book Value per Share | 11.38 | 13.13 | 15.48 | 17.19 | 24.19 | 23.26 | 21.13 | 18.50 | 16.67 |
| Total Shareholders' Equity | 562.53M | 638.99M | 736.74M | 819.68M | 1.16B | 1.04B | 831.26M | 706.62M | 642.11M |
| Common Stock | 484K | 488K | 493K | 496K | 498K | 501K | 504K | 507K | 511K |
| Retained Earnings | 142.23M | 286.06M | 400.05M | 469.56M | 796.95M | 1.24B | 1.45B | 1.3B | 1.21B |
| Treasury Stock | -33.42M | -100.44M | -119.14M | -119.14M | -121.83M | -698.6M | -1.13B | -1.13B | -1.13B |
| Accumulated OCI | -112K | 151K | 152K | 40K | -295K | -939K | -423K | -11K | 298K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AMN Healthcare Services, Inc. (AMN) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 115.26M | 226.99M | 224.86M | 256.83M | 305.36M | 653.73M | 372.17M | 320.42M | 269.46M |
| Operating CF Margin % | 5.8% | 10.63% | 10.12% | 10.73% | 7.66% | 12.47% | 9.82% | 10.74% | 9.87% |
| Operating CF Growth % | -12.58% | 96.94% | -0.94% | 14.21% | 18.9% | 114.09% | -43.07% | -13.9% | -15.9% |
| Net Income | 132.56M | 141.74M | 113.99M | 70.67M | 327.39M | 444.05M | 210.68M | -146.98M | 0 |
| Depreciation & Amortization | 32.28M | 41.24M | 58.52M | 94.19M | 103.7M | 137.11M | 160.93M | 173.78M | 0 |
| Stock-Based Compensation | 10.24M | 10.81M | 16.24M | 20.46M | 25.22M | 30.07M | 18.02M | 23.32M | 0 |
| Deferred Taxes | 5.61M | -667K | 913K | -21.63M | -16.29M | -24.61M | -12.93M | -51.07M | 0 |
| Other Non-Cash Items | 12.85M | 2.25M | 16.22M | 26.01M | 8.84M | 67.68M | 45.6M | 235.46M | 168.43M |
| Working Capital Changes | -78.27M | 31.61M | 18.98M | 67.13M | -143.49M | -558K | -50.13M | 85.91M | 101.03M |
| Change in Receivables | -10.64M | -10.58M | 5.71M | -8.61M | -585.27M | 20.04M | 224.85M | 219.44M | 74.75M |
| Change in Inventory | -32.63M | 14.56M | -1.93M | -5.56M | -256.12M | 0 | 0 | 0 | 0 |
| Change in Payables | -7.86M | 17.15M | 1.93M | 5.56M | 256.12M | 0 | 0 | 0 | -20.57M |
| Cash from Investing | -33.45M | -279.34M | -291.82M | -538.17M | -107.4M | -170.71M | -412.49M | -79.94M | 4.3M |
| Capital Expenditures | -26.53M | -36.39M | -36.46M | -39.1M | -53.66M | -75.83M | -103.69M | -80.89M | 0 |
| CapEx % of Revenue | 1.33% | 1.7% | 1.64% | 1.63% | 1.35% | 1.45% | 2.74% | 2.71% | 1.3% |
| Acquisitions | -1.5M | -217.36M | -247.91M | -476.43M | -41.26M | -69.5M | -292.1M | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -8.62M | -10.67M | -13.29M | -7.66M | -8.99M | -26.61M | -26.6M | -6.76M | 4.3M |
| Cash from Financing | -77.19M | 37.51M | 136.6M | 211.49M | -34.9M | -591.87M | 10.73M | -259.45M | -295.89M |
| Debt Issued (Net) | -44.06M | 120M | 180M | 240.54M | -21.88M | 0 | 459.7M | -250M | -293.8M |
| Equity Issued (Net) | -20.16M | -67.01M | -18.7M | -6.93M | -2.69M | -576.77M | -424.74M | 0 | -2.09M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -20.16M | -67.01M | -18.7M | -6.93M | -2.69M | -576.77M | -424.74M | 0 | -2.09M |
| Other Financing | -12.97M | -15.48M | -24.7M | -22.13M | -10.33M | -15.1M | -24.23M | -9.45M | 0 |
| Net Change in Cash | 4.53M▲ 0% | -14.57M▼ 422.0% | 69.64M▲ 578.0% | -69.97M▼ 200.5% | 162.72M▲ 332.6% | -108.84M▼ 166.9% | -29.6M▲ 72.8% | -18.97M▲ 35.9% | -22.13M▼ 16.7% |
| Free Cash Flow | 88.73M▲ 0% | 190.61M▲ 114.8% | 188.4M▼ 1.2% | 217.72M▲ 15.6% | 251.69M▲ 15.6% | 572.81M▲ 127.6% | 266.78M▼ 53.4% | 239.53M▼ 10.2% | 233.83M▼ 2.4% |
| FCF Margin % | 4.46% | 8.92% | 8.48% | 9.1% | 6.32% | 10.92% | 7.04% | 8.03% | 8.56% |
| FCF Growth % | -19.26% | 114.81% | -1.16% | 15.56% | 15.6% | 127.58% | -53.43% | -10.21% | -2.38% |
| FCF per Share | 1.80 | 3.92 | 3.96 | 4.57 | 5.24 | 12.77 | 6.78 | 6.27 | 6.07 |
| FCF Conversion (FCF/Net Income) | 0.87x | 1.60x | 1.97x | 3.63x | 0.93x | 1.47x | 1.77x | -2.18x | -2.82x |
| Interest Paid | 17.94M | 21.28M | 23.73M | 22.65M | 38.09M | 37.52M | 48.1M | 61.03M | 45.11M |
| Taxes Paid | 73.75M | 30.59M | 37.75M | 46.26M | 106.38M | 213.81M | 78.26M | 28.15M | 7.85M |
AMN Healthcare Services, Inc. (AMN) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 26.55% | 26.2% | 23.59% | 16.57% | 9.08% | 33.04% | 40.26% | 22.47% | -19.11% | -14.19% |
| Return on Invested Capital (ROIC) | 21.16% | 19.09% | 15.74% | 10.87% | 7.17% | 19.95% | 26.32% | 12.73% | -3.91% | 1.55% |
| Gross Margin | 32.58% | 32.41% | 32.6% | 33.46% | 33.08% | 32.87% | 32.74% | 32.98% | 30.81% | 22.93% |
| Net Margin | 5.56% | 6.67% | 6.64% | 5.13% | 2.95% | 8.22% | 8.47% | 5.56% | -4.93% | -3.5% |
| Debt / Equity | 0.81x | 0.57x | 0.69x | 0.98x | 1.17x | 0.75x | 0.82x | 1.62x | 1.55x | 1.25x |
| Interest Coverage | 12.39x | 10.80x | 12.56x | 6.22x | 2.59x | 14.03x | 16.02x | 6.25x | -1.47x | -1.22x |
| FCF Conversion | 1.25x | 0.87x | 1.60x | 1.97x | 3.63x | 0.93x | 1.47x | 1.77x | -2.18x | -2.82x |
| Revenue Growth | 30.02% | 4.53% | 7.42% | 4.03% | 7.72% | 66.45% | 31.6% | -27.73% | -21.26% | -8.49% |
AMN Healthcare Services, Inc. (AMN) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 4, 2026·SEC
Feb 19, 2026·SEC
Feb 5, 2026·SEC
AMN Healthcare Services, Inc. (AMN) stock FAQ — growth, dividends, profitability & financials explained
AMN Healthcare Services, Inc. (AMN) reported $2.73B in revenue for fiscal year 2025. This represents a 1083% increase from $230.8M in 2000.
AMN Healthcare Services, Inc. (AMN) saw revenue decline by 8.5% over the past year.
AMN Healthcare Services, Inc. (AMN) reported a net loss of $95.7M for fiscal year 2025.
AMN Healthcare Services, Inc. (AMN) has a return on equity (ROE) of -14.2%. Negative ROE indicates the company is unprofitable.
AMN Healthcare Services, Inc. (AMN) generated $233.8M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
AMN Healthcare Services, Inc. (AMN) financial analysis — history, returns, DCA and operating performance tools
Historical returns with dividends reinvested
Dollar cost averaging vs lump sum
Yield, growth, payout safety & DRIP
EPS trends, net income & profitability
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of market, efficiency and balance-sheet ratios
DCF intrinsic value, peer multiples & estimates